|
ERCC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.429900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.919900E-03 |
| Normal-vs-Stage2 |
5.680000E-01 |
| Normal-vs-Stage3 |
9.058600E-01 |
| Normal-vs-Stage4 |
7.483400E-01 |
| Stage1-vs-Stage2 |
2.352600E-01 |
| Stage1-vs-Stage3 |
2.443800E-01 |
| Stage1-vs-Stage4 |
3.715200E-01 |
| Stage2-vs-Stage3 |
7.851800E-01 |
| Stage2-vs-Stage4 |
9.857400E-01 |
| Stage3-vs-Stage4 |
8.633600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.499840E-02 |
| Normal-vs-AfricanAmerican |
2.252800E-01 |
| Normal-vs-Asian |
6.649800E-01 |
| Caucasian-vs-AfricanAmerican |
5.428000E-01 |
| Caucasian-vs-Asian |
3.167400E-01 |
| AfricanAmerican-vs-Asian |
4.871800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.117770E-03 |
| Normal-vs-Female |
3.648600E-01 |
| Male-vs-Female |
6.401900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.283630E-01 |
| Normal-vs-Extreme_Weight |
4.812200E-04 |
| Normal-vs-Obese |
4.230400E-01 |
| Normal-vs-Extreme_Obese |
9.157400E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.251000E-01 |
| Normal_Weight-vs-Obese |
4.188000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.883800E-01 |
| Extreme_Weight-vs-Obese |
2.243600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.298200E-01 |
| Obese-vs-Extreme_Obese |
1.996810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.669900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.613790E-01 |
| Normal-vs-Age(61-80Yrs) |
1.561880E-03 |
| Normal-vs-Age(81-100Yrs) |
3.79240000000225E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.039800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.603680E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.495400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.263700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.367890E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.980000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.727760E-02 |
| Normal-VS-Type2 PRCC |
2.07609999999248E-05 |
| Normal-VS-KIRP CIMP |
1.685520E-02 |
| Normal-VS-Unclassified PRCC |
8.252000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.761300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.262400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.538630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.140200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.901800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.580410E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.642600E-04 |
| Normal-vs-N1 |
4.447800E-01 |
| Normal-vs-N2 |
1.951380E-01 |
| N0-vs-N1 |
1.271770E-02 |
| N0-vs-N2 |
7.085400E-01 |
| N1-vs-N2 |
3.717000E-01 |
|
|
